Analysts Set Healthpeak Properties, Inc. (NYSE:DOC) PT at $22.93

Healthpeak Properties, Inc. (NYSE:DOC) has earned a consensus rating of “Moderate Buy” from the fifteen research firms that are currently covering the firm, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company. The average 12-month target price among brokers that have issued ratings on the stock in the last year is $23.62.

Several equities analysts recently weighed in on the company. Wells Fargo & Company lowered their target price on Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating on the stock in a research report on Tuesday, December 10th. Royal Bank of Canada lifted their price objective on Healthpeak Properties from $25.00 to $26.00 and gave the company an “outperform” rating in a research report on Monday, November 4th. Evercore ISI increased their target price on shares of Healthpeak Properties from $25.00 to $26.00 and gave the stock an “outperform” rating in a report on Monday, September 16th. StockNews.com downgraded shares of Healthpeak Properties from a “hold” rating to a “sell” rating in a report on Wednesday, October 30th. Finally, Scotiabank increased their price objective on shares of Healthpeak Properties from $23.00 to $24.00 and gave the stock a “sector outperform” rating in a research note on Monday, September 9th.

Institutional Trading of Healthpeak Properties

Hedge funds and other institutional investors have recently bought and sold shares of the business. State Street Corp bought a new position in Healthpeak Properties in the 3rd quarter worth about $1,093,576,000. Geode Capital Management LLC bought a new position in Healthpeak Properties in the third quarter worth approximately $403,898,000. Charles Schwab Investment Management Inc. purchased a new position in Healthpeak Properties during the 3rd quarter worth $230,988,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new stake in Healthpeak Properties during the 3rd quarter valued at $175,697,000. Finally, Sumitomo Mitsui Trust Group Inc. purchased a new stake in shares of Healthpeak Properties in the 3rd quarter worth $102,615,000. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Price Performance

NYSE DOC opened at $20.18 on Thursday. The stock has a market capitalization of $14.11 billion, a price-to-earnings ratio of 42.94, a PEG ratio of 2.37 and a beta of 1.13. Healthpeak Properties has a 1-year low of $16.01 and a 1-year high of $23.26. The company has a debt-to-equity ratio of 0.93, a current ratio of 1.31 and a quick ratio of 1.31. The business’s fifty day moving average price is $21.76 and its 200-day moving average price is $21.41.

Healthpeak Properties (NYSE:DOC) last posted its quarterly earnings data on Thursday, October 24th. The real estate investment trust reported $0.12 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.44 by ($0.32). The business had revenue of $700.40 million during the quarter, compared to analysts’ expectations of $682.51 million. Healthpeak Properties had a return on equity of 3.53% and a net margin of 12.10%. The business’s quarterly revenue was up 25.9% compared to the same quarter last year. During the same period in the previous year, the business posted $0.45 EPS. On average, equities analysts predict that Healthpeak Properties will post 1.8 earnings per share for the current year.

Healthpeak Properties Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Monday, November 4th were issued a dividend of $0.30 per share. The ex-dividend date was Monday, November 4th. This represents a $1.20 annualized dividend and a yield of 5.95%. Healthpeak Properties’s payout ratio is 255.32%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.